Global Induced Pluripotent Stem Cell Market Expected to Rise at a CAGR of 7.0% During 2018-2026
Induced pluripotent stem (iPS) cell technology has enormous potential to improve medical therapy by personalizing regenerative medicine and generating new human disease models for research and therapeutic testing. Despite the existence of various large-scale players as well as multiple regional companies in the global iPS cell market, very limited companies that have complete focus on being provider of life science reagents and products. Expenditure of companied on research and development activities is anticipated to provide lucrative growth opportunities for the...
View full press release